Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Notes Payables: 2020-2021

  • Mainz Biomed N.V's Notes Payables fell 7.23% to $22,754 in Q4 2021 from the same period last year, while for Dec 2021 it was $22,754, marking a year-over-year decrease of 7.23%. This contributed to the annual value of $22,754 for FY2021, which is 7.23% down from last year.
  • Latest data reveals that Mainz Biomed N.V reported Notes Payables of $22,754 as of Q4 2021, which was down 7.23% from $24,527 recorded in Q4 2020.
  • Mainz Biomed N.V's 5-year Notes Payables high stood at $24,527 for Q4 2020, and its period low was $22,754 during Q4 2021.
  • Moreover, its 2-year median value for Notes Payables was $23,640 (2020), whereas its average is $23,640.
  • Data for Mainz Biomed N.V's Notes Payables shows a maximum YoY dropped of 7.23% (in 2021) over the last 5 years.
  • Over the past 2 years, Mainz Biomed N.V's Notes Payables (Quarterly) stood at $24,527 in 2020, then dropped by 7.23% to $22,754 in 2021.